Tumors and new endoscopic ultrasound-guided therapies

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

450

HTML

3718

Figures (1-5)

250

Tables (1-2)

207

Sum=4625

Publishing Process of This Article

Item

Count

Browse

791

Download

654

Sum=1445

Apr 16, 2013 (publication date) through Nov 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastrointest Endosc. Apr 16, 2013; 5(4): 141-147
Published online Apr 16, 2013. doi: 10.4253/wjge.v5.i4.141

Table 1 Inclusion and exclusion criteria of patients treated with endoscopic ultrasound-guided cryotherm ablation

Inclusion criteria	Exclusion criteria
Age > 18 yr	Severe alteration of hemostasis
Able to give consent for the procedure	Unwilling or unable to give consent
	Pregnancy
PLT > 100 000/μL	Infection and/or severe leucopenia
INR < 1.5	Acute pancreatitis
Unresectable locally advanced pancreatic adenocarcinoma already treated with neoadjuvant chemotherapy	Distant metastasis

PLT: Platelet count; INR: International normalized ratio.

Citation: Carrara S, Petrone MC, Testoni PA, Arcidiacono PG. Tumors and new endoscopic ultrasound-guided therapies. World J Gastrointest Endosc 2013; 5(4): 141-147
URL: https://www.wjgnet.com/1948-5190/full/v5/i4/141.htm
DOI: https://dx.doi.org/10.4253/wjge.v5.i4.141